10 results
8-K
EX-10.1
NKGN
NKGen Biotech Inc
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
and documented out of pocket legal expenses whether or not there is a lawsuit, including attorney’s fees and legal expenses for bankruptcy proceedings (including
425
EX-2.1
NKGN
NKGen Biotech Inc
17 Apr 23
Business combination disclosure
6:02am
, or violation of Law or a claim or lawsuit or an environmental liability, (d) disclosed on Schedule 4.08, (e) arising under this Agreement
8-K
EX-2.1
NKGN
NKGen Biotech Inc
17 Apr 23
Entry into a Material Definitive Agreement
6:01am
, or violation of Law or a claim or lawsuit or an environmental liability, (d) disclosed on Schedule 4.08, (e) arising under this Agreement
10-K
kdn6u s0mg78
30 Mar 22
Annual report
9:27pm
424B4
evsr8b
24 May 21
Prospectus supplement with pricing info
5:01pm
S-1/A
nrjke7r c19
12 Apr 21
IPO registration (amended)
5:19pm
S-1
7upruv2
23 Feb 21
IPO registration
5:05pm
- Prev
- 1
- Next